New Early- Breast Cancer Drug to be Made Available in Australia, New Zealand and South East Asia Following License Deal

SINGAPORE and MELBOURNE, Australia, Nov. 22, 2017 /PRNewswire/ -- A NEW breast cancer drug shown to reduce the risk of cancer recurrence will soon be made available inAustralia, New Zealand and throughout South-East Asia, following a key license deal between Specialised Therapeutics Asia (ST Asia...